Dallah Healthcare Company SJSC
SAU:4004
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
154.2
188
|
Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dallah Healthcare Company SJSC
Income from Continuing Operations
Dallah Healthcare Company SJSC
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Dallah Healthcare Company SJSC
SAU:4004
|
Income from Continuing Operations
ď·Ľ470.9m
|
CAGR 3-Years
30%
|
CAGR 5-Years
32%
|
CAGR 10-Years
12%
|
||
National Medical Care Company JSC
SAU:4005
|
Income from Continuing Operations
ď·Ľ287.6m
|
CAGR 3-Years
40%
|
CAGR 5-Years
37%
|
CAGR 10-Years
11%
|
||
Mouwasat Medical Services Company SJSC
SAU:4002
|
Income from Continuing Operations
ď·Ľ691.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
||
A
|
Al Hammadi Holding Co
SAU:4007
|
Income from Continuing Operations
ď·Ľ322m
|
CAGR 3-Years
52%
|
CAGR 5-Years
31%
|
CAGR 10-Years
10%
|
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
Income from Continuing Operations
ď·Ľ2.1B
|
CAGR 3-Years
27%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
||
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
Income from Continuing Operations
ď·Ľ232m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Dallah Healthcare Company SJSC
Glance View
Dallah Healthcare Co. engages in the provision and operation of healthcare programs and utilities. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2012-12-16. The firm operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitals’ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicines’ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Office’s segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.
See Also
What is Dallah Healthcare Company SJSC's Income from Continuing Operations?
Income from Continuing Operations
470.9m
SAR
Based on the financial report for Jun 30, 2024, Dallah Healthcare Company SJSC's Income from Continuing Operations amounts to 470.9m SAR.
What is Dallah Healthcare Company SJSC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
12%
Over the last year, the Income from Continuing Operations growth was 18%. The average annual Income from Continuing Operations growth rates for Dallah Healthcare Company SJSC have been 30% over the past three years , 32% over the past five years , and 12% over the past ten years .